MedTrace Logo

Evaluating and Improving Functional Driving Vision of Patients With Astigmatism

NCT02624791 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2020-03-06

Study results available
· View outcomes & findings →

Summary

Small amounts of astigmatism are often uncorrected in contact lens wearers. The effect with respect to driving is unknown, but it could threaten safe operation of a motor vehicle, especially under conditions such as nighttime driving when visual abilities are highly challenged. This study measures driving-specific visual abilities and simulated driving performance in participants with astigmatism who either have or do not have their astigmatism corrected. The primary hypothesis is that at a tactical level, contact lenses correcting for astigmatism will result in safer driving performance overall. The secondary hypothesis is that at an operational level, contact lenses correcting for astigmatism will result in better driving-specific visual performance.

Conditions

  • Astigmatism

Interventions

DEVICE

1-DAY ACUVUE® MOIST contact lenses

spherical contact lenses worn during simulated driving tests

DEVICE

1-DAY ACUVUE® MOIST for ASTIGMATISM contact lenses

toric contact lenses worn during simulated driving tests

OTHER

No contact lenses

simulated driving tests

Sponsors & Collaborators

  • Johnson & Johnson Vision Care, Inc.

    collaborator INDUSTRY

  • University of Virginia

    lead OTHER

Principal Investigators

  • Daniel J Cox, Ph.D. · University of Virginia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02624791 on ClinicalTrials.gov